U-69593, kappa1-opioid receptor agonist (CAS 96744-75-1) (ab141703) | Abcam
Cara Therapeutics: Scratching An Itch Left Unscratched (NASDAQ:CARA) | Seeking Alpha
Antagonists of the kappa opioid receptor - ScienceDirect
Effects of Kappa Opioid Agonists on Cocaine- and Food-Maintained Responding by Rhesus Monkeys | Journal of Pharmacology and Experimental Therapeutics
Nalfurafine, a G-Protein–Biased KOR (Kappa Opioid Receptor) Agonist, Enhances the Diuretic Response and Limits Electrolyte Losses to Standard-of-Care Diuretics | Hypertension
Opioid Receptor | kappa, mu Opioid Receptor
Actions of mu, kappa, sigma, delta and agonist/antagonist opiates on striatal dopaminergic function. | Journal of Pharmacology and Experimental Therapeutics
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Mu Agonist Opioids and Kappa Opioids | Download Table
Figure 2 from Development of κ opioid receptor antagonists. | Semantic Scholar
The Kappa Opioid Receptor | SpringerLink
Kappa Antagonist - Pipeline Insight, 2022 - Research and Markets
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid Agonists
Effects of the Kappa Agonist U69,593 on Naltrexone's Discriminative Stimulus Effect in Subjects Given Chronic, Intermittent Sucrose Access
κ-Opioid Receptor (KOP) | 7TM Antibodies
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience
Kappa Receptors – Opioid Peptides
κ-opioid receptor - Wikipedia
BRL 52537 hydrochloride, kappa-opioid agonist (ab120669) | Abcam
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
HZ2, a Selective Kappa‐Opioid Agonist - Kögel - 1998 - CNS Drug Reviews - Wiley Online Library
Molecular mechanism of biased signaling at the kappa opioid receptor | Nature Communications
